Emerging Drugs for Relapsed or Refractory Peripheral T-Cell Lymphoma

Details

Files

Project Status:

Completed

Project Line:

Horizon Scan

Project Sub Line:

Emerging Health Technologies

Project Number:

EH0119-000

This Horizon Scan Bulletin provides information on advanced pipeline drugs intended to treat relapsed or refractory peripheral T-cell lymphoma (RR-PTCL). It describes the characteristics of completed phase II and III trials with published results evaluating drugs to treat RR-PTCL that are not currently approved by Health Canada or are under review.

Files

Emerging Drugs for Relapsed or Refractory Peripheral T-Cell Lymphoma View PDF

Last Updated : December 12, 2023